Orient Pharma Co., Ltd. (4166.TWO)
TWD 37.1
(-2.5%)
TWD 37.1
(-2.5%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 889.91 Million | 511.85 Million | 463.34 Million | 412.01 Million | 353.53 Million |
| Cost of Revenue | 421.24 Million | 356.51 Million | 320.66 Million | 336.86 Million | 339.85 Million |
| Gross Profit | 468.66 Million | 155.34 Million | 142.67 Million | 75.15 Million | 13.68 Million |
| Operating Expenses | 468.66 Million | 197.08 Million | 276.16 Million | 241.9 Million | 211.16 Million |
| Selling, General and Administrative Expenses | 341.01 Million | 67.83 Million | 56.44 Million | 57.97 Million | 65.43 Million |
| Research and Development Expenses | 99.9 Million | 129.25 Million | 219.71 Million | 183.93 Million | 153.62 Million |
| Other Expenses | - | 6.91 Million | 28.57 Million | 6.07 Million | - |
| Cost and Expenses | 862.15 Million | 553.59 Million | 596.83 Million | 578.76 Million | 551.01 Million |
| Operating Income | 27.75 Million | -33.73 Million | -104.39 Million | -160.26 Million | -205.36 Million |
| Interest Expense | 13.9 Million | 7.37 Million | 5.7 Million | 5.37 Million | 4.93 Million |
| Income Tax Expense | 636 Thousand | -12.34 Million | -7.44 Million | 5.73 Million | 1.38 Million |
| Earnings before Tax | 22.92 Million | -41.1 Million | -110.09 Million | -165.64 Million | -202.41 Million |
| Net Income | 22.28 Million | -28.75 Million | -102.65 Million | -171.37 Million | -201.02 Million |
| Earnings Per Share Basic | 0.10 | -0.15 | -0.55 | -1.01 | -1.29 |
| Earnings Per Share Diluted | 0.10 | -0.15 | -0.55 | -1.01 | -1.29 |
| Weighted Average Shares Outstanding | 222.88 Million | 187 Million | 187 Million | 169.39 Million | 156.02 Million |
| Weighted Average Shares Outstanding (Diluted) | 223.03 Million | 187 Million | 187 Million | 169.39 Million | 156.02 Million |
| Gross Margin | 0.53 | 0.30 | 0.31 | 0.18 | 0.04 |
| EBIT Margin | 0.19 | 0.07 | -0.08 | -0.23 | -0.43 |
| Profit Margin | 0.03 | -0.06 | -0.22 | -0.42 | -0.57 |
| EBITDA | 172.39 Million | 35.36 Million | -39.21 Million | -93.7 Million | -130.33 Million |
| Earnings Before Tax Margin | 0.03 | -0.07 | -0.23 | -0.39 | -0.58 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 301.48 Million | 301.48 Million | 889.91 Million | 231.33 Million | 231.33 Million | 213.61 Million |
| Cost of Revenue | 133.61 Million | 133.61 Million | 421.24 Million | 106.6 Million | 106.6 Million | 104.01 Million |
| Gross Profit | 167.87 Million | 167.87 Million | 468.66 Million | 124.73 Million | 124.73 Million | 109.6 Million |
| Operating Expenses | 108.13 Million | 102.94 Million | 440.91 Million | 108.37 Million | 108.37 Million | 108.38 Million |
| Selling, General and Administrative Expenses | 92.88 Million | 92.88 Million | - | 85.77 Million | 85.77 Million | 86.44 Million |
| Research and Development Expenses | 15.24 Million | 15.24 Million | - | 26.68 Million | 26.68 Million | 23.26 Million |
| Other Expenses | - | - | 10.83 Million | - | - | - |
| Cost and Expenses | 241.74 Million | 236.55 Million | 862.15 Million | 214.97 Million | 214.97 Million | 212.4 Million |
| Operating Income | 59.74 Million | 59.74 Million | 40.25 Million | 12.26 Million | 12.26 Million | -107 Thousand |
| Interest Expense | - | - | 13.9 Million | - | - | - |
| Income Tax Expense | 14.19 Million | 14.19 Million | 636 Thousand | 1.91 Million | 1.91 Million | 1.59 Million |
| Earnings before Tax | 62.69 Million | 62.69 Million | 22.92 Million | 12.95 Million | 12.95 Million | -1.49 Million |
| Net Income | 48.5 Million | 48.5 Million | 22.28 Million | 11.04 Million | 11.04 Million | 101.5 Thousand |
| Earnings Per Share Basic | 0.22 | 0.22 | - | 0.05 | 0.05 | 0.00 |
| Earnings Per Share Diluted | 0.22 | 0.22 | - | 0.05 | 0.05 | 0.00 |
| Weighted Average Shares Outstanding | 223.03 Million | 225.6 Million | 222.88 Million | 223.03 Million | 223.03 Million | 223.07 Million |
| Weighted Average Shares Outstanding (Diluted) | 223.03 Million | 225.6 Million | 222.88 Million | 223.03 Million | 223.03 Million | 223.03 Million |
| Gross Margin | 0.56 | 0.56 | 0.53 | 0.54 | 0.54 | 0.51 |
| EBIT Margin | 0.29 | 0.31 | - | 0.18 | 0.18 | 0.13 |
| Profit Margin | 0.16 | 0.16 | 0.03 | 0.05 | 0.05 | 0.00 |
| EBITDA | 88.75 Million | 93.98 Million | - | 41.25 Million | 41.25 Million | 28.23 Million |
| Earnings Before Tax Margin | 0.20 | 0.20 | 0.05 | 0.05 | 0.05 | -0.00 |
NATR
RPL
1729
HMU
300725
NCRBF